BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38581025)

  • 1. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
    Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
    BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of Proliferation 1 Promotes Proliferation, Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer.
    He J; Chen Z; Xue Q; Shi W
    Oxid Med Cell Longev; 2022; 2022():2946989. PubMed ID: 35222794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma.
    Huang Y; Zhou H; Zou J; Wang D
    Can J Gastroenterol Hepatol; 2022; 2022():9983351. PubMed ID: 35257007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
    Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
    Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer.
    Nishimura S; Yamamoto Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Kasashima H; Ohira M; Maeda K; Yashiro M
    Gastric Cancer; 2022 Sep; 25(5):850-861. PubMed ID: 35705840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
    PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
    Zhang X; Wu J
    Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 15. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway.
    Wei Y; Yin L; Xie X; Wu Z; Zhang J; Gao Y; Tang J
    Mutat Res; 2022; 825():111802. PubMed ID: 36274500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
    Zuo X; Cai J; Chen Z; Li Y; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer.
    He X; Cheng X; Ding J; Xiong M; Chen B; Cao G
    Bioengineered; 2022 Feb; 13(2):2902-2917. PubMed ID: 35094634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
    Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
    Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.